Aortic aneurysm and chronic disseminated intravascular coagulation: a retrospective study of 235 patients
- 135 Downloads
Chronic disseminated intravascular coagulation (DIC) is a rare but devastating complication of aortic aneurysm (AA). This study investigated the clinical manifestations, laboratory findings, and treatment of patients with AA-associated chronic DIC (AA-DIC) and explored the mechanisms, duration, and therapeutic response of AA-DIC. We retrospectively reviewed the medical records of 235 AA patients admitted at the Peking Union Medical College Hospital between September 2009 and January 2015. The patients were classified as those with DIC (AA-DIC) and those without DIC (non-DIC). The AA-DIC group showed a significantly higher proportion of female patients and a significantly longer AA disease course than the non-DIC group did. The AA-DIC patients presented mural thrombi, dissecting aneurysms, a family history of AA, and diabetes significantly more frequently than the non-DIC patients did. Furthermore, multiple regression analyses revealed that sex, mural thrombus, aneurysm type, diabetes, and stent surgery are possible independent risk factors for AA-DIC patients. Fifty-two (22.1%) patients presented AA-DIC. Among these patients, 43 had non-typical DIC and 9 had typical DIC; the mortality rate of the latter was 22.2%. The mean age of the patients with typical DIC was significantly higher than of that of patients with non-typical DIC. The non-typical DIC patients also presented abnormal coagulation disorders of varying degrees. Furthermore, heparin or low-molecular-weight heparin improved the clinical symptoms and laboratory parameters in patients with AA and typical DIC. Thus, chronic DIC should be considered in patients with AA.
Keywordsaortic aneurysm disseminated intravascular coagulation anticoagulation therapy
Unable to display preview. Download preview PDF.
We thank all of our colleagues at the Peking Union Medical College Hospital who were involved in patient care and medical records management and research.
- 1.Kasper DL, Harrison TR. Harrison’s Principles of Internal Medicine. 16th ed. New York: McGraw-Hill Medical Pub Division, 2005Google Scholar
- 3.Wada H, Gabazza EC, Asakura H, Koike K, Okamoto K, Maruyama I, Shiku H, Nobori T. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for overt DIC. Am J Hematol 2003; 74(1): 17–22CrossRefPubMedGoogle Scholar
- 9.Taylor FB, Toh CH, Hoots WK, Wada H, Levi M; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86(5): 1327–1330CrossRefPubMedGoogle Scholar
- 12.Liu W, Zhang L, Liu Y, Liu X, Xue F, Chen Y, Huang Y, Yang R. Chronic disseminated intravascular coagulopathy associated with aortic dissecting aneurysms: two cases report and literature review. Chin J Hematol (Zhonghua Xue Ye Xue Za Zhi) 2014; 35(9): 831–834 (in Chinese)Google Scholar
- 17.Sakamoto I, Matsuyama N, Fukushima A, Hayashi H, Nishida A, Hazama S, Noguchi M, Eishi K, Hayashi K. Chronic aortic dissection complicated by disseminated intravascular coagulation: successful treatment with endovascular stent-grafting. J Endovasc Ther 2003; 10(5): 953–957CrossRefPubMedGoogle Scholar
- 24.Iyama S, Sato T, Murase K, Kamihara Y, Ono K, Kikuchi S, Takada K, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J. Intermittent administration of recombinant human soluble thrombomodulin successfully controlled chronic disseminated intravascular coagulation in a patient with dissecting aortic aneurysm on an outpatient basis. Blood Coagul Fibrinolysis 2012; 23(6): 548–550CrossRefPubMedGoogle Scholar
- 25.Hayakawa K, Tamura S, Gima H, Hayakawa T, Kurihara T, Ooura M, Nakano Y, Souri M, Ichinose A, Fujimoto T. Successful treatment of chronic disseminated intravascular coagulation using recombinant human soluble thrombomodulin in a dialysis patient with dissecting aortic aneurysm. Rinsho Ketsueki 2014; 55(11): 2300–2305PubMedGoogle Scholar